Pomegranate Protection against Cardiovascular Diseases

被引:34
作者
Aviramand, Michael [1 ]
Rosenblat, Mira
机构
[1] Technion Israel Inst Technol, Rappaport Family Inst Res Med Sci, Lipid Res Lab, Fac Med, IL-31096 Haifa, Israel
关键词
LOW-DENSITY-LIPOPROTEIN; INTIMA-MEDIA THICKNESS; CORONARY-HEART-DISEASE; JUICE PJ CONSUMPTION; KAPPA-B ACTIVATION; E-O MICE; OXIDATIVE STRESS; ATHEROSCLEROTIC MICE; ANTIOXIDANT ACTIVITY; LIPID-PEROXIDATION;
D O I
10.1155/2012/382763
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
The current paper summarizes the antioxidative and antiatherogenic effects of pomegranate polyphenols on serum lipoproteins and on arterial macrophages (two major components of the atherosclerotic lesion), using both in vitro and in vivo humans and mice models. Pomegranate juice and its by-products substantially reduced macrophage cholesterol and oxidized lipids accumulation, and foam cell formation (the hallmark of early atherogenesis), leading to attenuation of atherosclerosis development, and its consequent cardiovascular events.
引用
收藏
页数:20
相关论文
共 70 条
  • [1] Suppression of the nuclear factor-κB activation pathway by spice-derived phytochemicals -: Reasoning for seasoning
    Aggarwal, BB
    Shishodia, S
    [J]. SIGNAL TRANSDUCTION PATHWAYS, CHROMATIN STRUCTURE, AND GENE EXPRESSION MECHANISMS AS THERAPEUTIC TARGETS, 2004, 1030 : 434 - 441
  • [2] Mechanism underlying oxidative stress-mediated lipotoxicity: Exposure of J774.2 macrophages to triacylglycerols facilitates mitochondrial reactive oxygen species production and cellular necrosis
    Aronis, A
    Madar, Z
    Tirosh, O
    [J]. FREE RADICAL BIOLOGY AND MEDICINE, 2005, 38 (09) : 1221 - 1230
  • [3] Aviram M, 2003, WINE: SCIENTIFIC EXPLORATION, P140
  • [4] Pomegranate juice consumption for 3 years by patients with carotid artery stenosis reduces common carotid intima-media thickness, blood pressure and LDL oxidation
    Aviram, M
    Rosenblat, M
    Gaitini, D
    Nitecki, S
    Hoffman, A
    Dornfeld, L
    Volkova, N
    Presser, D
    Attias, J
    Liker, H
    Hayek, T
    [J]. CLINICAL NUTRITION, 2004, 23 (03) : 423 - 433
  • [5] Aviram M, 1996, EUR J CLIN CHEM CLIN, V34, P599
  • [6] Aviram M, 2002, XI BIENNIAL MEETING OF THE SOCIETY FOR FREE RADICAL RESEARCH INTERNATIONAL, P523
  • [7] Aviram M, 2002, FREE RADICAL RES, V36, P72
  • [8] Aviram M, 2002, DRUG EXP CLIN RES, V28, P49
  • [9] Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants
    Aviram, M
    Rosenblat, M
    Billecke, S
    Erogul, J
    Sorenson, R
    Bisgaier, CL
    Newton, RS
    La Du, B
    [J]. FREE RADICAL BIOLOGY AND MEDICINE, 1999, 26 (7-8) : 892 - 904
  • [10] Aviram M, 2000, FREE RADICAL RES, V33, pS85